MedTrace Logo

22G-Adapt Needle Biopsy Versus Fine-needle Aspiration in Endoscopic Ultrasound-guided Sampling of Solid Lesions

NCT06563232 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 656

Last updated 2024-08-20

No results posted yet for this study

Summary

The investigators conduct a multicenter randomized controlled study to evaluate the diagnostic value and safety of 22G Adapt Aspiration puncture needle for histopathology of solid lesions.

Conditions

  • Pancreatic Neoplasms
  • Mediastinal Neoplasms
  • Abdominal Neoplasm, Excluding Pancreas Neoplasm

Interventions

DEVICE

FNA group

Fine-needle-aspiration (22G EchoTip Ultra Echo-3-22)

DEVICE

Adapt FNB group

Fine-needle-biopsy (22G Adapt Aspiration)

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    collaborator OTHER

  • Fudan University

    collaborator OTHER

  • Qilu Hospital of Shandong University

    collaborator OTHER

  • Chongqing University Cancer Hospital

    collaborator OTHER

  • The First Affiliated Hospital of Zhengzhou University

    collaborator OTHER

  • Huazhong University of Science and Technology

    lead OTHER

Principal Investigators

  • Bin Cheng · Tongji Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2025-12-01
Completion
2026-02-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06563232 on ClinicalTrials.gov